Abstract
Cervical cancer is the fourth most common cancer in women worldwide, and the human papillomavirus (HPV) is the main causative agent for its development. HPV is a heterogeneous virus, and a persistent infection with a high-risk HPV contributes to the development of cancer. In recent decades, great advances have been made in understanding the molecular biology of HPV, and HPV’s significance in cervical cancer prevention and management has received increased attention. In this review, we discuss the role of HPV genotyping in cervical cancer by addressing: clinically important issues in HPV virology; the current application of HPV genotyping in clinical medicine; and potential future uses for HPV genotyping.
| Original language | English |
|---|---|
| Journal | Journal of Gynecologic Oncology |
| Volume | 27 |
| Issue number | 2 |
| DOIs | |
| State | Published - Mar 2016 |
Bibliographical note
Publisher Copyright:© 2016. Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology.
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- DNA tests
- Genotype
- Human papillomavirus
- Uterine cervical neoplasms
- Vaccine
Fingerprint
Dive into the research topics of 'Clinical significance of human papillomavirus genotyping'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver